PF

Per Falholt

Europe, Hovedstaden, Denmark, Copenhagen

Description

A passion and vision for chemistry and biotechnology led Per (born 1958) to Novo A/S, where he started his career as a research chemist. He ...

Investor Profile

Per Falholt has made 5 investments, with 3 in the past 12 months and 40% as lead.

Stage Focus

  • Pre Seed (60%)
  • Series A (20%)
  • Seed (20%)

Country Focus

  • Denmark (80%)
  • United States (20%)

Industry Focus

  • Biotechnology
  • Machine Learning
  • Industrial Automation
  • Robotics
  • Artificial Intelligence (Ai)
  • Life Science
  • Pharmaceutical
  • Therapeutics
  • Building Material
  • Wholesale
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Per Falholt frequently co-invest with?

Astanor Ventures
Europe, Luxembourg, Belgium, Luxembourg
Co-Investments: 1
EF
North America, South Carolina, United States, Denmark
Co-Investments: 1
ACME Capital
North America, Florida, United States, Boca Raton
Co-Investments: 2
FundersClub
North America, California, United States, San Francisco
Co-Investments: 1
Look Up Ventures
Europe, Hovedstaden, Denmark, Copenhagen
Co-Investments: 1
Y Combinator
North America, California, United States, Mountain View
Co-Investments: 2
R7 Partners
North America, Illinois, United States, Chicago
Co-Investments: 1
21st.BIO
Europe, Hovedstaden, Denmark, Virum
Co-Investments: 1

Which angels does Per Falholt often collaborate with?

NF
Europe, Hovedstaden, Denmark, Copenhagen
Shared Deals: 2
DK
Europe, England, United Kingdom, London
Shared Deals: 1
SR
Europe, Denmark
Shared Deals: 2

What are some of recent deals done by Per Falholt?

Visibuilt

Allerød, Hovedstaden, Denmark

Visibuilt is to pioneer sustainable road-building solutions by replacing standard asphalt with cutting-edge, environmentally materials.

Building MaterialWholesale
Pre SeedFeb 1, 2025
Amount Raised: $1,139,929
Synamics Therapeutics

San Francisco, California, United States

Synamics Therapeutics is rethinking and reshaping drug discovery by staying ahead of disease evolution

Artificial Intelligence (AI)BiotechnologyLife ScienceMachine LearningPharmaceuticalTherapeutics
Pre SeedNov 1, 2024
Synamics Therapeutics

Copenhagen, Hovedstaden, Denmark

Pioneering AI-Driven Drug Discovery to Combat Drug Resistance in Cancer

Artificial Intelligence (AI)BiotechnologyLife ScienceMachine LearningPharmaceuticalTherapeutics
Pre SeedJul 10, 2024
Reshape Biotech

Kongens Lyngby, Hovedstaden, Denmark

Reshape Biotech builds lab robots that automate the everyday tasks of microbiologists, from filling plates to analyzing images.

BiotechnologyIndustrial AutomationMachine LearningRobotics
Series AApr 9, 2024
Amount Raised: $20,000,000
Reshape Biotech

Kongens Lyngby, Hovedstaden, Denmark

Reshape Biotech builds lab robots that automate the everyday tasks of microbiologists, from filling plates to analyzing images.

BiotechnologyIndustrial AutomationMachine LearningRobotics
SeedFeb 9, 2023
Amount Raised: $8,100,000